Clinical findings for patients with Lyme borreliosis caused by Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities to strain 25015

Clinical Infectious Diseases

Volumn 25, Issue 2, 1997, Pages 273-280

  Strle, Franc ^b   Picken, Roger N ^b   Cheng, Yu ^b   Cimperman, Joze ^b   Maraspin, Vera ^b   Lotric Furlan, Stanka ^b   Ruzic Sabljic, Eva ^b   Picken, Maria M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GENOME; GENOTYPE; HUMAN; LYME DISEASE; MALE; PHENOTYPE; PRIORITY JOURNAL; SLOVENIA; STRAIN DIFFERENCE; TICK;

EID: 0030809451     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514551     Document Type: Article

References (14)

1. Steere AC. Lyme disease. N Engl J Med 1989; 321:586-96.
2. Sbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodesborne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann NY Acad Sci 1988; 539:4-15.
3. Weber K, Pfister H-W, Reimers CD. Clinical features of Lyme borreliosis: clinical overview. In: Weber K, Burgdorfer W, eds. Aspects of Lyme borreliosis. Berlin: Springer-Verlag, 1993:93-104.
4. Asbrink E, Hovmark A. Cutaneous manifestations in Ixodes-borne Borrelia spirochetosis. Int J Dermatol 1987; 26:215-23.
5. Postic D, Edlinger C, Richaud C, et al. Two genomic species in Borrelia burgdorferi. Res Microbiol 1990; 141:465-75.
6. Baranton G, Postic D, Saint Girons I, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992; 42:378-83.
7. Canica MM, Nato F, du Merle L, Mazie JC, Baranton G, Postic D. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis 1993;25:441-8.
8. Postic D, Assous MV, Grimont PAD, Baranton G. Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf(5S)-rrl(23S) intergenic spacer amplicons. Int J Syst Bacteriol 1994;44:743-52.
9. Marconi RT, Liveris D, Schwartz I. Identification of novel insertion elements, restriction fragment length polymorphism patterns, and discontinuous 23S rRNA in Lyme disease spirochetes: phylogenetic analyses of rRNA genes and their intergenic spacers in Borrelia japonica sp. nov. and genomic group 21038 (Borrelia andersonii sp. nov.) isolates. J Clin Microbiol 1995; 33:2427-34.
10. Kawabata H, Masuzawa T, Yanagihara Y. Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan. Microbiol Immunol 1993; 37:843-8.
11. Assous MV, Postic D, Paul G, Névot P, Baranton G. Individualisation of two new genomic groups among American Borrelia burgdorferi sensu lato strains. FEMS Microbiol Lett 1994; 121:93-8.
12. Picken RN, Cheng Y, Strle F, Picken MM. Patient isolates of Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities to strain 25015. J Infect Dis 1996; 174:1112-5.
13. Wilske B, Schierz G, Preac-Mursic V, Weber K, Pfister H-W, Einhäupl K. Serological diagnosis of erythema migrans disease and related disorders. Infection 1984; 12:331-7.
14. Strle F, Cheng Y, Cimperman J, et al. Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions. Clin Infect Dis 1995; 21:380-9.